Cargando…

P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW-UP OF THE SEQUOIA STUDY

Detalles Bibliográficos
Autores principales:	Munir, Talha, Shadman, Mazyar, Robak, Tadeusz, R. Brown, Jennifer, Kahl, Brad, Ghia, Paolo, Giannopoulos, Krzysztof, Simkovic, Martin, Österberg, Anders, Laurenti, Luca, Walker, Patricia, Opat, Stephen, Ciepluch, Hanna, Greil, Richard, Hanna, Merit, Tani, Monica, Trneny, Marek, M. Brander, Danielle, W. Flinn, Ian, Grosicki, Sebastian, Verner, Emma, Tedeschi, Alessandra, De Guibert, Sophie, Tumyan, Gayane, Laribi, Kamel, Antonio Garcia Marco, Jose, LI, Jianyong, Tian, Tian, Ramakrishnan, Vanitha, Liu, Yu, Szeto, Andy, Paik, Jason, Cohen, Aileen, Tam, Constantine, Jurczak, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429085/ http://dx.doi.org/10.1097/01.HS9.0000969460.15364.af

Ejemplares similares